+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Triarylmethane dyes as therapeutic agents for the photochemical purging of autologous bone marrow grafts from residual tumor cells



Triarylmethane dyes as therapeutic agents for the photochemical purging of autologous bone marrow grafts from residual tumor cells



Biophysical Journal 78(1 Part 2): 256A




(PDF emailed within 1 workday: $29.90)

Accession: 035985982

Download citation: RISBibTeXText


Related references

Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells. Journal of Pharmaceutical Sciences 89(1): 88-99, 2000

Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Experimental Hematology 25(7): 629-637, 1997

The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. Progress in Clinical and Biological Research 389: 601-609, 1994

Elimination of residual tumor cells from autologous bone marrow grafts using monoclonal antibodies. Oldham, R K (Ed ) Principles Of Cancer Biotherapy X+502p Raven Press: New York, New York, Usa Illus 355-384, 1987

Elimination of residual tumor cells from autologous bone marrow grafts by dye-mediated photolysis: preclinical data. Photochemistry and Photobiology 46(1): 71-76, 1987

Ethacrynic acid enhances the merocyanine 540-mediated purging of leukemia cells from autologous bone marrow grafts. Blood 86(10 SUPPL 1): 235A, 1995

Transferrin ricin a chain for ex vivo purging of small cell carcinoma cells from autologous bone marrow grafts. Clinical Research 38(1): 17A, 1990

A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow. Progress in Clinical and Biological Research 389: 105-109, 1994

Residual leukemic cells in autologous marrow grafts do not significantly contribute to leukemia relapse after bone marrow transplantation. Experimental Hematology (Charlottesville) 16(6): 492, 1988

Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging?. Cancer Investigation 5(2): 113-118, 1987

Photoradiation methods for purging autologous bone marrow grafts. Progress in Clinical and Biological Research 333: 87-102, 1990

The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells. Medical Oncology 11(2): 47-51, 1994

Purging bone marrow for autologous transplantation are methods for monitoring the elimination of tumor cells reliable?. Experimental Hematology (Charlottesville) 11(SUPPL 14): 7, 1983

The role of methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells. Medical Oncology (Northwood) 11(2): 47-51, 1994

Immunomagnetic removal of residual tumor cells from human bone marrow prior to autologous bone marrow transplantation. Onkologie 14(SUPPL 2): 180, 1991